Longtime Tesla investor Ross Gerber on why Musk’s ties to Trump might not boost the EV makerPatricia Kaliati Bitter with Saulos Chilima
OneDigital Investment Advisors LLC lowered its stake in shares of Corvus Pharmaceuticals, Inc. ( NASDAQ:CRVS – Free Report ) by 31.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,000 shares of the company’s stock after selling 4,550 shares during the quarter. OneDigital Investment Advisors LLC’s holdings in Corvus Pharmaceuticals were worth $53,000 as of its most recent SEC filing. Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Vanguard Group Inc. raised its stake in Corvus Pharmaceuticals by 10.6% in the 1st quarter. Vanguard Group Inc. now owns 1,493,357 shares of the company’s stock worth $2,658,000 after acquiring an additional 142,724 shares during the last quarter. Towerview LLC increased its holdings in shares of Corvus Pharmaceuticals by 4.6% in the second quarter. Towerview LLC now owns 400,000 shares of the company’s stock valued at $728,000 after purchasing an additional 17,500 shares during the period. Samlyn Capital LLC raised its stake in shares of Corvus Pharmaceuticals by 160.7% in the second quarter. Samlyn Capital LLC now owns 6,123,021 shares of the company’s stock worth $11,144,000 after purchasing an additional 3,774,658 shares during the last quarter. Marshall Wace LLP acquired a new stake in Corvus Pharmaceuticals during the 2nd quarter valued at approximately $136,000. Finally, Cubist Systematic Strategies LLC acquired a new position in Corvus Pharmaceuticals during the second quarter valued at $44,000. 46.64% of the stock is owned by hedge funds and other institutional investors. Corvus Pharmaceuticals Stock Performance NASDAQ:CRVS opened at $8.95 on Friday. Corvus Pharmaceuticals, Inc. has a one year low of $1.30 and a one year high of $10.00. The stock has a market cap of $575.13 million, a PE ratio of -9.62 and a beta of 1.05. The stock has a 50 day moving average price of $7.22 and a 200 day moving average price of $4.29. Wall Street Analyst Weigh In View Our Latest Research Report on CRVS About Corvus Pharmaceuticals ( Free Report ) Corvus Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers, T cell lymphomas, autoimmune, allergic, and infectious diseases. Its lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1/1b clinical trial for the treatment of peripheral T cell lymphoma, solid tumors, and atopic dermatitis. See Also Five stocks we like better than Corvus Pharmaceuticals How to Invest in the FAANG Stocks Vertiv’s Cool Tech Makes Its Stock Red-Hot EV Stocks and How to Profit from Them MarketBeat Week in Review – 11/18 – 11/22 What Are Dividend Contenders? Investing in Dividend Contenders 2 Finance Stocks With Competitive Advantages You Can’t Ignore Want to see what other hedge funds are holding CRVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corvus Pharmaceuticals, Inc. ( NASDAQ:CRVS – Free Report ). Receive News & Ratings for Corvus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corvus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter .NASHVILLE, Tenn (AP) — Josh Heupel made clear his No. 7 Tennessee Volunteers couldn't have started their regular season finale any worse giving up 14 points within the first five minutes. The Vols showed they can finish, which has them on the verge of hosting a College Football Playoff game. Nico Iamaleava threw for 257 yards and four touchdowns rallying Tennessee to routing in-state rival Vanderbilt 36-23 Saturday. “Finishing the way that we needed to and that we wanted to always is sweet, and these guys earned the right for this to be a big game," Heupel said. "They went out, they took it.” The Volunteers (10-2, 6-2 Southeastern Conference; No. 8 CFP) needed a big victory to impress the College Football Playoff committee. They beat Vanderbilt (6-6, 3-5) for a sixth straight season leaving the Commodores needing to win their bowl game to post their first winning record since 2013. Better yet, the Vols rebounded from a nightmare start giving up the first 14 points by scoring 29 straight points. They led 24-17 at halftime on Iamaleava's first three TD passes. “Once they took the momentum, we kind of allowed them to have it for the rest of the game," Vanderbilt coach Clark Lea said. "And you got to credit Tennessee. I mean, obviously, they were playing for the playoffs and credit coach Heupel and his team for their winning performance.” Junior Sherrill returned the opening kickoff 100 yards for a touchdown for Vanderbilt to stun a mostly orange crowd. Dylan Sampson fumbled on the Vols’ second play from scrimmage, and Sedrick Alexanader's 4-yard TD run on a 26-yard drive put Vandy up 14-0 quickly. Then Iamaleava got Tennessee going with a 28-yard TD pass to Dont’e Thornton Jr. Tennessee got a break when Max Gilbert's 50-yard field goal bounced off the crossbar and over. Iamaleava found Thornton again on an 86-yard catch-and-run TD, then he tossed an 18-yard TD pass to Miles Kitselman. “Nico I just thought played really well throughout the course of the football game ...,” Heupel said. An early interception remained on Iamaleava's mind postgame. He also scrambled six times for 42 yards and wasn't sacked once. “I still feel like I can do better,” Iamaleava said. Iamaleava capped the opening drive of the third quartewith a 14-yard TD pass to Mike Matthews. The Vols added a safety by Tyre West and another Gilbert field goal. Diego Pavia threw a 31-yard TD pass to Richie Hoskins late with Vandy's 2-point conversion failing for the final margin. Tennessee shook off yet another slow start. The Vols may move up a spot or two . The biggest question is whether the Vols get to host a playoff game at Neyland Stadium where they went undefeated. Tennessee put together TD drives of 91 and 96 yards in the first half. The Vols then beat Vandy at its own game of keepaway after not even managing 10 minutes of possession in the first half. They finished with the edge in that stat outgaining Vandy 538-212. Vanderbilt had some of the best offensive success against Tennessee in the first half of any opponent this season. The Commodores had 114 yards rushing and 17 points by halftime against a defense that came in ranked sixth nationally allowing just 98.8 yards a game. The Vols also held 10 opponents under 20 points this season. Lea said the Commodores ran just 11 plays to Tennessee's 44 after halftime. The Tennessee running back, who set the program record with 22 rushing TDs this season, didn't reach the end zone for the first time this season. Sampson finished with 178 yards rushing to reach 1,485 yards for the season, topping the school mark of 1,464 set by Travis Stephens in 2001. “I don’t know if anybody’s played the position better than he has this year,” Heupel said of a running back who wasn't among the Doak Walker finalists. “He’s special. He's dynamic.” Tennessee waits to hear its spot in the CFP field, while Vanderbilt learns its bowl destination Dec. 8. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football.
Deficit soars as Biden heads out the door
Rajasthan Govt To Introduce Bill To Prevent Illegal Conversions
Mission will be the first RCMP detachment in B.C. to roll out the use of body-worn cameras, beginning the week of Nov. 25. It's the first of the six initial rollouts and will be followed by Ucluelet, Tofino (including Ahousaht), Prince George, Cranbrook and Kamloops, B.C. RCMP said during a news conference in Surrey Thursday (Nov. 21). In total in B.C., 3,000 officers in 144 detachments serving 150 municipalities will be using body-worn cameras. RCMP did not provide specific dates yet for the first six rollouts, but said a release would go out from each detachment to inform the public. B.C. RCMP commanding officer Dwayne McDonald said this represents the "largest and most ambitious rollout of body-worn cameras in the province." He said the body-worn cameras is "expected to promote transparency, to strengthen accountability and to enhance officer and public safety." "Basically, how this works is that when one of our members responds to a call for service and begins to engage with a person, the camera is activated and you will see frontline officers wearing the cameras in front of their vests on a regular basis." Officers are expected to activate their body-worn camera before exiting their vehicle. Body-worn cameras are expected to be activated for crimes in progress, investigations, public disorder and protests, mental health calls, interactions with people in crisis and "to record information to support the performance of their duties." McDonald said the while the cameras are worn, they are on standby, which means they're always buffering and capturing 30 seconds of video without audio. He said it's "essentially writing over that 30 seconds constantly," but once the camera is activated it attaches the 30 seconds without audio to the rest of the video. "It's in the best interest of our officers to capture the video," McDonald said. "I think it's important to remember that in addition to calls from public for greater transparency ... and accountability for police, it's also in police's best interest to give the objective viewpoint of what's happening in interactions with the public." In B.C., police agencies have watchdogs including, the Independent Investigations Office and the Office of the Police Complaint Commissioner. Nationally, there is the Civilian Review and Complaints Commission, which is an independent agency tasked with examining RCMP conduct. The Independent Investigations Office, which investigates police's actions or inactions into incidents of death or serious harm, doesn't force an officer under investigation to be interviewed or submit notes, reports or data. McDonald said the IIO would absolutely have access to the even if the officer chooses to not submit anything. He added those agencies will have access to unvetted – generally redacted – versions of the footage to conduct oversight investigations. "That's where the transparency and accountability comes from." He said he completely understands the "public's desire, and in some cases, curiosity to know right away what happens, but we do have to respect the privacy legislation." The RCMP's federal headquarters announced the national rollout Nov. 14. Over the next nine months, 1,000 officers will start using the body-worn cameras each month. Ninety per cent of the RCMP officers will be using the cameras in the next year, with the full rollout completed within 18 months. The RCMP is not the first to rollout body-worn cameras in B.C. The Delta Police Department, in the Lower Mainland, has been using the technology for more than two years. At a news conference in January 2024, the department anticipated it would have about 37 body-worn cameras in operation.Cal Baptist makes cross-country trip to battle Darius Johnson, UCFThese three women were upskirted. Their lives have never been the same again
Toronto Sceptres open PWHL season with 3-1 comeback win over Boston FleetNone
NEW YORK--(BUSINESS WIRE)--Nov 24, 2024-- Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of AMMO, Inc. (NASDAQ: POWW) between August 19, 2020 and September 24, 2024. AMMO describes itself as a “company that designs, produces, and markets ammunition and ammunition component products for public consumers, manufacturers, and law enforcement and military agencies.” For more information, submit a form , email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that AMMO, Inc. (NASDAQ: POWW) Misled Investors Regarding its Business Operations. According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) AMMO lacked adequate internal controls over financial reporting; (2) there was a substantial likelihood AMMO failed to accurately disclose all executive officers, members of management, and potential related party transactions in fiscal years 2020 through 2023; (3) there was a substantial likelihood AMMO failed to properly characterize certain fees paid for investor relations and legal services as reductions of proceeds from capital raises rather than period expenses in fiscal years 2021 and 2022; (4) there was a substantial likelihood AMMO failed to appropriately value unrestricted stock awards to officers, directors, employees and others in fiscal years 2020 through 2022; and (5) as a result of the foregoing, defendants’ positive statements about AMMO’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against AMMO, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by November 29, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here . All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ . Attorney Advertising. Prior results do not guarantee a similar outcome. View source version on businesswire.com : https://www.businesswire.com/news/home/20241124774051/en/ CONTACT: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com KEYWORD: NEW YORK UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL SOURCE: The Rosen Law Firm, P.A. Copyright Business Wire 2024. PUB: 11/24/2024 09:01 AM/DISC: 11/24/2024 09:01 AM http://www.businesswire.com/news/home/20241124774051/en
DAYTONA BEACH, Fla. (AP) — Tyler McGhie had 27 points in UC San Diego's 72-67 win against La Salle on Thursday. McGhie also added seven rebounds for the Tritons (3-2). Nordin Kapic scored 18 points and added 10 rebounds. Hayden Gray had 14 points and shot 4 for 8 (3 for 6 from 3-point range) and 3 of 6 from the free-throw line. The Explorers (4-1) were led by Corey McKeithan, who recorded 21 points. Jahlil White added 13 points and seven rebounds. The second half featured five lead changes and was tied five times before UC San Diego secured the victory. Kapic scored 13 second-half points. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .
Cal Baptist makes cross-country trip to battle Darius Johnson, UCF
By Niki Bezzant * Opinion - I'm in a department store changing room trying on swimsuits and I can't move. The one-piece I'm attempting to get into is halfway up; the bottom half is on my body, but my arms are pinned to my sides by the top half. I can't get it up and I can't get it down, either. I'm literally stuck, and I can't stop laughing. Were my sister not in the room with me, I probably wouldn't be laughing, because I'd be panicking that I might never get free. Luckily, the situation is resolved with some tugging and two sets of hands. I'll never know how I look in that swimsuit. I'm here in pursuit of on-the-ground knowledge of the state of the swimsuit landscape. This comes from a conversation with my editor about the apparent lack of swimwear to suit bodies that are not model-like in proportion and/or under the age of 23. Plus, there's my need to replace my 10-year-old worn-out suit with something new. It turns out that things have changed a lot in the decade since I last bought a pair of togs. The prevailing trend now seems to be for skimpy swimsuits (so skimpy that people are sometimes offended by them . Even when they're not cut to be g-string in style, it feels like they show more butt than in times past. Browse around online and you'll soon discover even a so-called 'classic' cut reveals more than it ever has. This can be an issue for women who are not so keen to bare their cheeks on the beach (see: over 23, over a size 8). I try not to hate any parts of my body, and I don't hate my bum. It's got me through 54 years, it's OK by me. But I'd still rather not show it to the whole world in the bright sunshine. My Instagram community - primarily mid-life women - is in agreement. "I want to swim and play at the beach. I accept my body in togs, but I want to cover my private parts!" pleads one woman. "I can't be bothered waxing. Togs with a low cut veering to boyleg would be great," says another. One woman told me she'd even written to a swimwear brand: "They were advertising togs for every body, in a wide range of sizes. I suggested that women might not want to show their bums, but they were very insistent that that was what women wanted and I should take my delusions elsewhere." When I mention this dilemma to a colleague, she tells me she and her book club had an hour-long discussion about how hard it is to find good togs, just the day before. "I don't want my bum hanging out," she agrees. "Is it too much to ask for something that isn't just floss?" Compounding the problem: the opportunities for real-life swimwear shopping have diminished. A lot of swimsuit shopping is now done online, which is a pretty hit-and-miss affair. Often suits we like the look of from the front are disappointing on closer inspection of the rear. Even the models in the photos don't look great in some of them. My colleague texts me later about the emotional rollercoaster ride of online shopping. "That's always my thought process... 'That looks cute, that looks cute' and then RAGE - it's cut up the bum. And/or it's got no boob support." What women are seeking in the ideal swimwear varies, of course, from woman to woman. Some women are super comfortable in teeny suits. Others are looking for more coverage, which for them offers security, comfort, freedom of movement and confidence - important when you're as close to naked as you're ever likely to be in public. Deborah Lewthwaite, expert swimwear salesperson and general manager of The Fitting Room (a specialist underwear and swimwear store with branches in Wellington and Christchurch), says it's rare to find a woman who's not even a little bit daunted by the idea of shopping for swimmers. "People come trudging in as if they're going to the dentist," she says. Lewthwaite says her fitters are as much psychologists as salespeople. They even have staff training to help deal with women's negative self-talk about their bodies. "It happens particularly with swimwear. I think people are more self-conscious because they're going to be wearing it outside. And it can actually be quite hard for fitters, hearing a lot of that negative talk." Lewthwaite says women can often be very focussed on one small part of their bodies, like a muffin top - which others barely notice. She tries to be encouraging. "We're happy to give our thoughts. But ultimately people have to go with what they are going to feel comfortable wearing into the water." While I'm trying on swimsuits at Hot Body, an Auckland swimwear store, I ask the very helpful salesperson where the trend for high-cut swim bottoms has come from. She tells me it's a design thing; if suits are cut larger in the back, it makes the bum appear larger overall. Leaving aside the issue of what's so bad about a large bum, it's possible there's some truth to this, Lewthwaite reckons. "Sometimes a boyleg style is what people think they want in their head. But then they put them on and go, 'actually no, that's not as flattering as this other brief that comes up a bit higher'. But there's still a happy medium between the really high cut and skimpy, and the more medium coverage." She wonders if the trend for revealing swimwear might come from social media. "People are enjoying showing more; they're more confident in their bodies maybe, in social posts?" Lewthwaite speculates that the general trend of clothing overall being less modest than it used to be might also be at play here. We've got more comfortable and less prudish about showing our bodies. She concedes, however, "that doesn't necessarily relate to what is most flattering". A happy medium is, she stresses, possible to find, and she relishes helping her customers find it. She offers some tips for finding that holy grail swimsuit. Take some time and try on a few suits, she says. "It's the only way you can know if they're going to suit you and look good." For those of us in our 40s or older, she recommends a medium height leg as the most flattering, usually. "Don't go too low. And if you feel comfortable going high, go for it." She also advises looking to what suits us in clothes. If you like high-neck tops, try higher-neck swimwear. If you feel great in a low-v neck, that could be a good option for togs, too. For those needing bust support, "there are underwire swimsuits out there that are bra-sized, and it's well worth looking for them". Lewthwaite says to look out for brands that produce trusted styles on repeat. "If you see a shape that's common and it's in lots of different prints and fabrics, it's probably a winner shape. It's worth trying that one." In my retail travels, it's clear the price range of swimwear is wide - from a $17 Kmart bikini bottom to suits that cost hundreds at specialist stores. The very nicest suit I try on is from a German label; it fits my short torso perfectly, doesn't dig in or sag out anywhere and though the bum is cut a little higher than I'm used to, it stays put while I'm doing my comical squatting and marching tests. It does, however, cost $399. Lewthwaite says there is an element of getting what you pay for with togs. "There will be differences in the quality of the fabrics and how long things will last and how quickly they'll fade and stretch," she notes. There are also more brands producing suits in recycled and sustainable fabrics, which might cost a little more. And, she says, it's likely more work has gone into the design process in a pricier pair, so it's more likely to suit a range of bodies. It is good to see that across all price points and despite the high-cut trend, there is in a wide range of options out there, including boy legs and even swim skirts. My Instagram wāhine provide me with a long list of useful leads. An interesting thing happens in my head as I'm tooling around town trying on togs. I, too, go in feeling dread - I'm expecting this process to leave me feeling a bit less than in love with my body. I do have some of those feelings (harsh fitting room lighting does no favours). But after a while - and maybe after getting stuck in that suit that clearly has some kind of fatal design flaw - I start to feel acceptance again. There are definitely swimsuits that don't suit me. But when that happens, I don't blame my body. I blame the suit. I do try on some uncomfortably 'cheeky' options. Somehow, though, after a while my perception changes. I slowly get used to seeing more of my own cheeks. They're part of me. It starts to feel okay. I narrow it down to a couple of tog options in which I'd be happy to be on the beach. Lewthwaite says her customers often go through a similar experience, and can be pleasantly surprised to find swimwear in which they feel good. The day after our chat, she emails me. She's been thinking about swimwear and body image, and she thinks it goes a bit deeper than just needing something to cover us. "Body confidence is a big or small issue for most of us," she writes. "There are a lot of paradoxes around bodies. You might have asked a bigger question that you realised." *Niki Bezzant is a freelance writer, speaker, journalist and author focusing on health, wellbeing and science.Josh Gottheimer trades in Microsoft options, buys and sells various stocksEmbecta ( NASDAQ:EMBC – Get Free Report ) and RenovaCare ( OTCMKTS:RCAR – Get Free Report ) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk. Profitability This table compares Embecta and RenovaCare’s net margins, return on equity and return on assets. Volatility & Risk Embecta has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Comparatively, RenovaCare has a beta of -99.34, indicating that its share price is 10,034% less volatile than the S&P 500. Analyst Recommendations Embecta currently has a consensus price target of $19.00, suggesting a potential downside of 8.79%. Given RenovaCare’s higher probable upside, analysts clearly believe RenovaCare is more favorable than Embecta. Institutional & Insider Ownership 93.8% of Embecta shares are held by institutional investors. 0.3% of Embecta shares are held by company insiders. Comparatively, 0.9% of RenovaCare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Earnings & Valuation This table compares Embecta and RenovaCare”s revenue, earnings per share and valuation. Embecta has higher revenue and earnings than RenovaCare. Summary Embecta beats RenovaCare on 8 of the 11 factors compared between the two stocks. About Embecta ( Get Free Report ) Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey. About RenovaCare ( Get Free Report ) RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona. Receive News & Ratings for Embecta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embecta and related companies with MarketBeat.com's FREE daily email newsletter .
Trump's plans for tougher border enforcement won't necessarily stop migrants from coming to U.S. − but their journeys could become more costly and dangerousFlorida man arrested for alleged terror plot against New York Stock ExchangeToronto Sceptres open PWHL season with 3-1 comeback win over Boston Fleet